nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—MAOA—conduct disorder	0.545	0.608	CbGaD
Phentermine—SLC6A4—conduct disorder	0.351	0.392	CbGaD
Phentermine—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—conduct disorder	0.0154	0.159	CbGpPWpGaD
Phentermine—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—conduct disorder	0.00972	0.1	CbGpPWpGaD
Phentermine—MAOB—Amine Oxidase reactions—MAOA—conduct disorder	0.00883	0.091	CbGpPWpGaD
Phentermine—MAOA—Clearance of dopamine—COMT—conduct disorder	0.00703	0.0724	CbGpPWpGaD
Phentermine—SLC6A3—Clearance of dopamine—COMT—conduct disorder	0.00653	0.0673	CbGpPWpGaD
Phentermine—SLC6A3—Clearance of dopamine—MAOA—conduct disorder	0.00649	0.0668	CbGpPWpGaD
Phentermine—MAOB—Dopamine metabolism—COMT—conduct disorder	0.00347	0.0357	CbGpPWpGaD
Phentermine—MAOB—Dopamine metabolism—MAOA—conduct disorder	0.00344	0.0355	CbGpPWpGaD
Phentermine—MAOA—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.00328	0.0338	CbGpPWpGaD
Phentermine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00321	0.033	CbGpPWpGaD
Phentermine—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00301	0.031	CbGpPWpGaD
Phentermine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00298	0.0307	CbGpPWpGaD
Phentermine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00296	0.0305	CbGpPWpGaD
Phentermine—MAOA—Dopamine metabolism—COMT—conduct disorder	0.00217	0.0224	CbGpPWpGaD
Phentermine—MAOA—Biogenic Amine Synthesis—COMT—conduct disorder	0.00194	0.02	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.00146	0.0151	CbGpPWpGaD
Phentermine—Pargyline—MAOA—conduct disorder	0.0013	0.203	CrCbGaD
Phentermine—SLC6A3—Monoamine Transport—SLC6A4—conduct disorder	0.0013	0.0134	CbGpPWpGaD
Phentermine—CYP1A2—Methylation—COMT—conduct disorder	0.000989	0.0102	CbGpPWpGaD
Phentermine—Tranylcypromine—MAOA—conduct disorder	0.000838	0.131	CrCbGaD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000821	0.00846	CbGpPWpGaD
Phentermine—Phenylpropanolamine—MAOA—conduct disorder	0.000788	0.123	CrCbGaD
Phentermine—Pseudoephedrine—MAOA—conduct disorder	0.000666	0.104	CrCbGaD
Phentermine—Selegiline—MAOA—conduct disorder	0.00065	0.101	CrCbGaD
Phentermine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000618	0.00637	CbGpPWpGaD
Phentermine—Phenelzine—MAOA—conduct disorder	0.000572	0.0893	CrCbGaD
Phentermine—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000507	0.00523	CbGpPWpGaD
Phentermine—Methamphetamine—MAOA—conduct disorder	0.0005	0.078	CrCbGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000495	0.0051	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000471	0.00486	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—COMT—conduct disorder	0.000439	0.00452	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—MAOA—conduct disorder	0.000436	0.00449	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.000435	0.00448	CbGpPWpGaD
Phentermine—Pseudoephedrine—SLC6A4—conduct disorder	0.000429	0.0669	CrCbGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000419	0.00432	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000393	0.00405	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—GABRA2—conduct disorder	0.000389	0.00401	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—SLC6A4—conduct disorder	0.000385	0.00397	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.000368	0.00379	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—GABRA2—conduct disorder	0.000361	0.00372	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000361	0.00372	CbGpPWpGaD
Phentermine—Amphetamine—SLC6A4—conduct disorder	0.000348	0.0543	CrCbGaD
Phentermine—Methamphetamine—SLC6A4—conduct disorder	0.000323	0.0503	CrCbGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000294	0.00303	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—COMT—conduct disorder	0.000275	0.00284	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000244	0.00252	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000241	0.00248	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000227	0.00234	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000225	0.00232	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000224	0.00231	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000222	0.00229	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000219	0.00226	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000194	0.002	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00019	0.00196	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—COMT—conduct disorder	0.000187	0.00193	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—COMT—conduct disorder	0.000174	0.00179	CbGpPWpGaD
Phentermine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000174	0.00179	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—MAOA—conduct disorder	0.000173	0.00178	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CGA—conduct disorder	0.000166	0.00171	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000156	0.00161	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000128	0.00132	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000127	0.00131	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000125	0.00129	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000125	0.00129	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00012	0.00124	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000119	0.00123	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000119	0.00123	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000118	0.00122	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000118	0.00122	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000117	0.00121	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CGA—conduct disorder	0.000104	0.00108	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000102	0.00105	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000101	0.00104	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000101	0.00104	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.0001	0.00103	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.64e-05	0.000891	CbGpPWpGaD
Phentermine—MAOB—Metabolism—COMT—conduct disorder	7.51e-05	0.000774	CbGpPWpGaD
Phentermine—MAOB—Metabolism—MAOA—conduct disorder	7.45e-05	0.000768	CbGpPWpGaD
Phentermine—MAOA—Metabolism—COMT—conduct disorder	4.71e-05	0.000485	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CGA—conduct disorder	4.54e-05	0.000468	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CGA—conduct disorder	4.5e-05	0.000464	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CGA—conduct disorder	3.85e-05	0.000397	CbGpPWpGaD
Phentermine—MAOB—Metabolism—EP300—conduct disorder	3.22e-05	0.000332	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—COMT—conduct disorder	2.05e-05	0.000211	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—MAOA—conduct disorder	2.04e-05	0.00021	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—COMT—conduct disorder	2.03e-05	0.00021	CbGpPWpGaD
Phentermine—MAOA—Metabolism—EP300—conduct disorder	2.02e-05	0.000208	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—MAOA—conduct disorder	2.02e-05	0.000208	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.96e-05	0.000202	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—COMT—conduct disorder	1.74e-05	0.000179	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—MAOA—conduct disorder	1.73e-05	0.000178	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.67e-05	0.000172	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—EP300—conduct disorder	8.79e-06	9.06e-05	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—EP300—conduct disorder	8.72e-06	8.99e-05	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—EP300—conduct disorder	7.45e-06	7.68e-05	CbGpPWpGaD
